Dr. Lal PathLabs Limited (NSE: LALPATHLAB) reported a Revenue from Operations of ₹489.4 Crores, a decline of 1.5% from the previous year. The Consolidated Net Profit for the business also decreased by 8% year over year, to ₹53.6 Crore from ₹58.2 Crore. Earnings per Share is ₹6.35 for this quarter.
Dr. Lal PathLabs Limited Q3 FY23; Net Profit Down By 8%
Tags: Healthcare Services
Related Post
- Sula Vineyards Limited posts lower Q3 FY26 profit as tactical destocking hits margins; wine tourism revenue rises
Sula Vineyards Limited (NSE: SULA, BSE: 543711) reported lower profit for the quarter ended Dec.…
-
Filatex India Limited posts stable Q3 FY26 revenue as margins improve on product mix and efficiency gains
Filatex India Limited (NSE: FILATEX, BSE: 526227) reported stable revenue and improved profitability for the…
-
Man Industries (India) Limited reports strong Q3 FY26 earnings as margins expand and order book rises
Man Industries (India) Limited (NSE: MANINDS, BSE: 513269) reported a sharp increase in revenue, profit…